N-[3-[[5-fluoro-2-(6-methylpyrazolo[4,5-b]pyridin-1-yl)pyrimidin-4-yl]amino]cyclohexyl]pyridine-2-carboxamide
C23H23FN8O — CID 130344272
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[[5-fluoro-2-(6-methylpyrazolo[4,5-b]pyridin-1-yl)pyrimidin-4-yl]amino]cyclohexyl]pyridine-2-carboxamide
N-[3-[[5-fluoro-2-(6-methylpyrazolo[4,5-b]pyridin-1-yl)pyrimidin-4-yl]amino]cyclohexyl]pyridine-2-carboxamide (PubChem CID 130344272) has the molecular formula C23H23FN8O and a molecular weight of 446.49 g/mol. Its IUPAC name is N-[3-[[5-fluoro-2-(6-methylpyrazolo[4,5-b]pyridin-1-yl)pyrimidin-4-yl]amino]cyclohexyl]pyridine-2-carboxamide.
Molecular Properties
| Compound Name | N-[3-[[5-fluoro-2-(6-methylpyrazolo[4,5-b]pyridin-1-yl)pyrimidin-4-yl]amino]cyclohexyl]pyridine-2-carboxamide |
|---|---|
| PubChem CID | 130344272 |
| Molecular Formula | C23H23FN8O |
| Molecular Weight | 446.49 g/mol |
| Exact Mass | 446.20 |
| IUPAC Name | N-[3-[[5-fluoro-2-(6-methylpyrazolo[4,5-b]pyridin-1-yl)pyrimidin-4-yl]amino]cyclohexyl]pyridine-2-carboxamide |
| SMILES | Cc1cnc2cnn(-c3ncc(F)c(NC4CCCC(NC(=O)c5ccccn5)C4)n3)c2c1 |
| InChI | InChI=1S/C23H23FN8O/c1-14-9-20-19(26-11-14)13-28-32(20)23-27-12-17(24)21(31-23)29-15-5-4-6-16(10-15)30-22(33)18-7-2-3-8-25-18/h2-3,7-9,11-13,15-16H,4-6,10H2,1H3,(H,30,33)(H,27,29,31) |
| InChIKey | IHAVQWHRBSCPNN-UHFFFAOYSA-N |
| XLogP | 3.21 |
| TPSA | 110.51 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 446.49 |
| LogP ≤ 5 | 3.21 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 130344272 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.